Department of Thoracic Oncology;
Cancer Center;
State Key Laboratory of Biotherapy;
West China Hospital;
West China Medical School;
Sichuan University and Collaborative Innovation Center for Biotherapy;
Chengdu 610041;
China;
Department of Neurosurgery and Institute of Neurosurgery;
State Key Laboratory of Biotherapy and Cancer Center;
West China Hospital;
West China Medical School;
Sichuan University and Collaborative Innovation Center for Biotherapy;
Chengdu 610041;
China;
Doxorubicin; Curcumin; Lung cancer; Nanomicelle; Co-delivery;